Article Information
History
- July 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ahmed O. Hassan1,
- Natasha M. Kafai1,3,
- Igor P. Dmitriev2,
- Julie M. Fox1,
- Brittany Smith5,
- Ian B. Harvey5,
- Rita E. Chen1,3,
- Emma S. Winkler1,3,
- Alex W. Wessel1,3,
- James Brett Case1,
- Elena Kashentseva2,
- Broc T. McCune1,
- Adam L. Bailey3,
- Haiyan Zhao3,
- Laura A. VanBlargan1,
- Yanan Dai3,
- Meisheng Ma3,
- Lucas J. Adams3,
- Swathi Shrihari1,
- Lisa E. Gralinski9,
- Yixuan J. Hou9,
- Alexandra Schaefer9,
- Arthur S. Kim1,3,
- Shamus P. Keeler6,
- Daniela Weiskopf8,
- Ralph Baric9,10,
- Michael J. Holtzman1,6,
- Daved H. Fremont3,5,7,
- David T. Curiel2,7,* and
- Michael S. Diamond1,3,4,7,*
- 1Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- 2Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA
- 3Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA
- 4Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA
- 5Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA
- 6Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- 7The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO 63110, USA
- 8Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA
- 9Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 10Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- ↵*Corresponding authors: David T. Curiel (dcuriel{at}wustl.edu) and Michael S. Diamond, M.D., Ph.D. (diamond{at}wusm.wustl.edu)
Posted July 17, 2020.
A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection
